Kohichi Nakashiro

5PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Sep 30, 2024
Serum CXCL13 as a Novel Biomarker in Oral Squamous Cell Carcinoma.

Shin Tojo, Koh-Ichi Nakashiro, Nobuyuki Kuribayashi

|Apr 27, 2024
Possible Role of miR-375-3p in Cervical Lymph Node Metastasis of Oral Squamous Cell Carcinoma.

Masato Saika, Koh-Ichi Nakashiro, Norihiko Tokuzen

|Aug 26, 2023
MicroRNA-1289 Functions as a Novel Tumor Suppressor in Oral Squamous Cell Carcinoma.

Koh-Ichi Nakashiro, Norihiko Tokuzen, Masato Saika

|Mar 11, 2023
Radiotherapy Plus Cetuximab for Squamous Cell Carcinoma of the Oral Cavity: A Multicenter Retrospective Study of 79 Patients in Japan.

Mitsunobu Otsuru, Souichi Yanamoto, Shin-Ichi Yamada

|Feb 23, 2020
MicroRNA-361-3p is a potent therapeutic target for oral squamous cell carcinoma.

Himiko Ogawa, Koh-Ichi Nakashiro, Norihiko Tokuzen

Pageof 1